New Novartis R&D centre in China
Fabrice Martin
Swiss pharmaceutical lab company Novartis announced its 8th R&D centre in Shanghaï, China.Mainly dedicated to research on infectious causes of prevalent cancers in China, this centre represents a USD 100 million investment. By establishing its new centre, which should employ more than 400 researchers by 2008, at the Zhangjiang Hi-Tech Park, near Shanghaï, Novartis bets on the development of this emerging life science cluster.
Operations are set to begin in May 2007.
More information about ABG?
Get ABG’s monthly newsletters including news, job offers, grants & fellowships and a selection of relevant events…
Thesis topic
Ref. ABG99558
MINES ParisTech - PSL
Valbonne - Sophia Antipolis - Provence-Alpes-Côte d'Azur - France
Offre de thèse CEMEF 2021 : Impacts des cocktails de contaminants provenant des plastiques dans les écosystèmes du sol
Biotechnology - Biochemistry - Chemistry
Job
Permanent
Ref. ABG99548
CESI
Nanterre - Ile-de-France - France
Enseignant Chercheur Innovation Produit H/F
Open to all scientific expertises
Junior